← Return to Recovery time after Anastrozole/aromatase inhibitors

Discussion
Comment receiving replies
Profile picture for marygrannie @marygrannie

Encouraged to find out by the end of this November, whether the new drug (instead of Arimidex) called Giredestrant will be FDA approved for early stage BC. It is not supposed to have the harsh side effects, and in the trials, not as many women stopped taking it early; the way so many of us did with Arimidex. Such an improvement would be welcome. I was 73, only took Arimidex for 2 months before it knocked me for a loop. The oncologist said to stop taking it. My recurrence rate went from 3% to 5%, so not a big difference. I was to the point where I couldn’t even withstand a trip to the grocery store without being down and out for hours afterward. Aces and pains and no stamina. Hair shedding was terrible. Interesting that some women have almost zero side effects and they are so fortunate. I am still using topical foam Minoxidil daily to get my hair back in shape.

Jump to this post


Replies to "Encouraged to find out by the end of this November, whether the new drug (instead of..."

@marygrannie yes I think this is a research area that begs exploration - are there specific genetic triggers that cause some people to be so severely affected?